Fluorine 18 fluorodeoxyglucose PET/CT volume-based indices in locally advanced non-small cell lung cancer: prediction of residual viable tumor after induction chemotherapy
- PMID: 24761836
- DOI: 10.1148/radiol.14132191
Fluorine 18 fluorodeoxyglucose PET/CT volume-based indices in locally advanced non-small cell lung cancer: prediction of residual viable tumor after induction chemotherapy
Abstract
Purpose: To study whether volume-based indices of fluorine 18 fluorodeoxyglucose positron emission tomographic (PET)/computed tomographic (CT) imaging is an accurate tool to predict the amount of residual viable tumor after induction chemotherapy in patients with locally advanced non-small cell lung cancer (NSCLC).
Materials and methods: This study was approved by institutional review board with waivers of informed consent. Twenty-two patients with locally advanced NSCLC underwent surgery after induction chemotherapy. All had pre- and posttreatment FDG PET/CT scans. CT largest diameter, CT volume, maximum standardized uptake value (SUVmax), mean SUV (SUVmean), metabolic tumor volume (TV), and total lesion glycolysis of primary tumor were calculated. Changes in tumor measurements were determined by dividing follow-up by baseline measurement (ratio index). Amounts of residual viable tumor, necrosis, fibrous tissue, inflammatory infiltrate, and Ki-67 proliferative index were estimated on resected tumor. Correlations between imaging indices and histologic parameters were estimated by using Spearman correlation coefficients or Mann-Whitney tests.
Results: No baseline or posttreatment indices correlated with percentage of residual viable tumor. TV ratio was the only index that correlated with percentage of residual viable tumor (r = 0.61 [95% confidence interval: 0.24, 0.81]; P = .003). Conversely, SUVmax and SUVmean ratios were only indices correlated with Ki-67 (r = 0.62 [95% confidence interval: 0.24, 0.82]; P = .003; and r = 0.60 [95% confidence interval: 0.21, 0.81]; P = .004, respectively). Total lesion glycolysis ratio was moderately correlated with residual viable tumor (r = 0.53 [95% confidence interval: 0.13, 0.78]; P = .01) and with Ki-67 (r = 0.57 [95% confidence interval: 0.18, 0.80]; P = .006). No ratios were correlated with presence of inflammatory infiltrate or foamy macrophages.
Conclusion: TV and total lesion glycolysis ratios were the only indices correlated with residual viable tumor after induction chemotherapy in locally advanced NSCLC.
Similar articles
-
Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.Eur J Radiol. 2012 Dec;81(12):4179-84. doi: 10.1016/j.ejrad.2012.07.009. Epub 2012 Aug 9. Eur J Radiol. 2012. PMID: 22884163
-
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.Rofo. 2013 Nov;185(11):1056-62. doi: 10.1055/s-0033-1350110. Epub 2013 Jul 16. Rofo. 2013. PMID: 23860802 Clinical Trial.
-
Relationship between primary lesion metabolic parameters and clinical stage in lung cancer.Rev Esp Med Nucl Imagen Mol. 2013 Nov-Dec;32(6):357-63. doi: 10.1016/j.remn.2013.03.008. Epub 2013 Jun 6. Rev Esp Med Nucl Imagen Mol. 2013. PMID: 23747221
-
Spontaneous remission of advanced progressive poorly differentiated non-small cell lung cancer: a case report and review of literature.BMC Pulm Med. 2019 Nov 11;19(1):210. doi: 10.1186/s12890-019-0978-4. BMC Pulm Med. 2019. PMID: 31711463 Free PMC article. Review.
-
Partial-volume effect in PET tumor imaging.J Nucl Med. 2007 Jun;48(6):932-45. doi: 10.2967/jnumed.106.035774. Epub 2007 May 15. J Nucl Med. 2007. PMID: 17504879 Review.
Cited by
-
Prognostic value of post-induction chemotherapy 18F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation.PLoS One. 2019 Oct 11;14(10):e0222885. doi: 10.1371/journal.pone.0222885. eCollection 2019. PLoS One. 2019. PMID: 31603916 Free PMC article.
-
PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis.Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1753-64. doi: 10.1007/s00259-016-3356-y. Epub 2016 Mar 19. Eur J Nucl Med Mol Imaging. 2016. PMID: 26993317
-
Meta-research: How many diagnostic or prognostic models published in radiological journals are evaluated externally?Eur Radiol. 2024 Apr;34(4):2524-2533. doi: 10.1007/s00330-023-10168-3. Epub 2023 Sep 12. Eur Radiol. 2024. PMID: 37696974 Free PMC article.
-
Correlation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography related parameters with the degree of proliferation in lung adenocarcinoma.Sci Rep. 2025 Jul 1;15(1):20978. doi: 10.1038/s41598-025-05165-z. Sci Rep. 2025. PMID: 40594300 Free PMC article.
-
Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial.J Thorac Oncol. 2016 Apr;11(4):537-44. doi: 10.1016/j.jtho.2015.12.104. Epub 2015 Dec 25. J Thorac Oncol. 2016. PMID: 26724474 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical